Gynion & IdleSmart

At its meeting the morning of Flag Day 2022, Beacon Angels members considered funding proposals from the following companies:

  • Mr. Oleg Shikhman, CEO, Gynion—developing MenorrxTM treatment for Heavy Menstrual Bleeding (HMB), Menorrx is a safe and effective endometrial ablation therapy that is simpler, easier to use, and costs a fraction of the available alternatives;
  • Mr. Jeff Lynch, CEO, presenting remotely regarding IdleSmart—offering a proprietary IoT solution for truck fleets to reduce yearly fuel costs of $10,000 per truck while increasing vehicle uptime and availability; and
  • Mr. Doug Godfrin, CEO, who delivered an update on Veramorph, which reformulates generic drugs for oral efficacy and is co-developing a diverse portfolio of new drugs with a beachhead in the oral delivery of a drug treatment for metastatic breast cancer.

There followed a due diligence report on Pointz Mobility, a safety-focused mapping app that leverages crowdsourcing to help guide bike and scooter riders through pleasant, lower-stress routes in cities.

Members reported on the funding rounds of:

TopProp Fantasy, which has finalized the terms of its convertible note; and

Imago Rehab, which has accepted an extension of BA Series 99’s investment.

Members delivered company updates.

About Angel Treaty

Dedicated to fostering due diligence sharing between angel groups.
This entry was posted in Beacon Angels Events, Beacon Angels Exits, Beacon Events, Boston angel investing and tagged , , , , . Bookmark the permalink.